Literature DB >> 1696374

Activities of calcitonin gene-related peptide (CGRP) and related peptides at the CGRP receptor.

P N Maton1, T Pradhan, Z C Zhou, J D Gardner, R T Jensen.   

Abstract

In guinea pig pancreatic acini rat calcitonin gene-related peptide (CGRP) increased amylase release 2-fold, salmon calcitonin had an efficacy of only 44% of that of CGRP and [Tyr0]CGRP(28-37) and human calcitonin had no actions. [Tyr0]CGRP(28-37), but not human calcitonin, antagonized the actions of CGRP in pancreatic acini with an IC50 of 3 microM. [Tyr0]CGRP(28-37) produced a parallel rightward shift in the dose-response curve for CGRP-stimulated amylase secretion. The inhibition was specific for CGRP and was reversible. Studies with 125I-CGRP demonstrated that CGRP, salmon calcitonin and [Tyr0]CGRP, but not human calcitonin, interacted with CGRP receptors on pancreatic acini. These results indicate that various CGRP-related peptides demonstrate different relationships between their abilities to occupy the CGRP receptor and to affect biologic activity, with CGRP itself being a full agonist, salmon calcitonin a partial agonist, [Tyr0]CGRP(28-37) a competitive antagonist, and human calcitonin having no actions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696374     DOI: 10.1016/0196-9781(90)90047-9

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  The role of CGRP and afferent nerves in the modulation of pancreatic enzyme secretion in the rat.

Authors:  J Jaworek; S J Konturek; A Szlachcic
Journal:  Int J Pancreatol       Date:  1997-10

2.  Regional haemodynamic effects of prolonged infusions of human alpha-calcitonin gene-related peptide in conscious, Long Evans rats.

Authors:  S M Gardiner; A M Compton; P A Kemp; T Bennett; R Foulkes; B Hughes
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

3.  Effects of calcitonin gene-related peptide receptor antagonists on renal actions of adrenomedullin.

Authors:  A M Elhawary; J Poon; C C Pang
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.